Showing results (61-70 of 183) with videos related to

Sort By:
Pageof 19
Journal of Pharmaceutical and Biomedical Analysis|March 22, 2020
Measurement of total and unbound bictegravir concentrations in plasma and cerebrospinal fluid by UHPLC-MS/MSRaúl Rigo-Bonnin, Juan Manuel Tiraboschi, Marta Álvarez-Álvarez, et al.
AIDS (London, England)|December 14, 2019
Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patientsChloe Orkin, Joseph J Eron, Jürgen Rockstroh, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 10, 2002
Resistance mutations in HIV-infected patients experiencing early failure with nelfinavir-containing triple combinationsMarina Núńez, Carmen de Mendoza, Luisa Valer, et al.
Antiviral Therapy|December 15, 2015
Cerebrospinal fluid and plasma lopinavir concentrations and viral response in virologically suppressed patients switching to lopinavir/ritonavir monotherapy once dailyJuan M Tiraboschi, Hernando Knobel, Arkaitz Imaz, et al.
AIDS (London, England)|December 17, 2009
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunctionEsteban Martínez, María Larrousse, Daniel Podzamczer, et al.
The Journal of Infectious Diseases|February 25, 2003
Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapineElena Ferrer, Daniel Podzamczer, Mireia Arnedo, et al.
The Journal of Antimicrobial Chemotherapy|March 2, 2012
Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimenJoaquin Burgos, Manuel Crespo, Vicenç Falcó, et al.
AIDS Research and Human Retroviruses|August 2, 2008
Zidovudine/lamivudine/abacavir plus tenofovir in HIV-infected naive patients: a 96-week prospective one-arm pilot studyElena Ferrer, Jose Maria Gatell, Pochita Sanchez, et al.
The Journal of Antimicrobial Chemotherapy|January 14, 2014
Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study GroupAdrian Curran, Polyana Monteiro, Pere Domingo, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|September 6, 2016
Cost-effectiveness of initial antiretroviral treatment administered as single vs. multiple tablet regimens with the same or different componentsJosep M Llibre, Elisa de Lazzari, Jean-Michel Molina, et al.
Pageof 19